$175.0

Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common StockMineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock

Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock

March 11, 2025 22:20 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

3 days ago